Morning Read: Obama to sit down with biopharma CEOs to talk Trans-Pacific Partnership agreement
Also, CytomX Therapeutics brings in $80 million, Vertera Spine won FDA 510(k) clearance and John Boehner is stalling on a deal that could potentially create massive increases in Medicare premiums.